Abstract

Objective To investigate the clinical and pathological features of patients with a combination of Sjogren's syndrome (SS) and antineutrophil cytoplasmic antibody (ANCA) associated vasculitis with renal involvement. Methods By searching the Peking Union Medical College Hospital medical database and literature between January 1990 and June 2017, patients had a combination of SS and ANCA associated vasculitis with renal involvement were included. Data of clinical information, autoimmune antibodies, renal manifestations and renal pathology were retrieved and analyzed. Results Eighteen patients were enrolled: 4 from our hospital and 14 from literature. SS was diagnosed no later than ANCA associated vasculitis in all the patients, among which 83.3%(15/18) of patients had extra-glandular and extra-renal organs involved. All the patients were tested positive for myeloperoxidase (MPO)-ANCA, and only two were protein 3 (PR3)-ANCA positive concurrently. The positivity rates of antinuclear antibody (ANA), rheumatoid factor (RF), anti-SSA antibody, and anti-SSB antibody were 83.3%(15/18), 55.6%(10/18), 77.8%(14/18), and 38.9%(7/18), respectively. The renal manifestations were characterized by renal insufficiency with a median serum creatinine of 174 μmol/L, hematuria, moderate proteinuria with a median 24 hour urine protein of 1.70 g, and necrotizing vasculitis with oligo-immune complex and varying degrees of interstitial damage in pathology. Conclusions A combination of Sjogren's syndrome and ANCA associated vasculitis with renal involvement is rare in clinical setting, and almost all of the patients are MPO-ANCA positive, with high probability of ANA positivity and extra-glandular involvement. Physicians should beware of ANCA associated glomerulonephritis in SS patients with inexplicable renal dysfunction and renal biopsy should be carried out in time. Key words: Sjogren's syndrome; Anti-neutrophil cytoplasmic antibody-associated vasculitis; Anti-neutrophil cytoplasmic antibody-associated glomerulonephritis

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.